Michael Kelly

Michael Kelly

DirectoratNeogenomics· In proxies 2023–2025

Michael Kelly sits on 4 public boards.

Boards1

  • NeogenomicsDirector · 5 yr on the boardIndependentAudit and Finance (Chair), Culture and Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. NeogenomicsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +98%
  2. Amicus TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  3. DMC Global, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Prime Medicine, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?